In the fast-paced environment of a gross room, accuracy and efficiency are paramount. Every tissue sample processed plays a crucial role in patient care, so proper and timely specimen evaluation from the outset can significantly impact diagnostic accuracy and treatment decisions. This is where specimen radiography steps in, providing real-time imaging to support Pathologists' Assistants (PAs), Pathology Residents, and Pathologists in their daily workflow.

Sentinel lymph node biopsy (SLNB) is an increasingly valuable procedure in cancer care, particularly for melanoma and breast cancer. By isolating and testing sentinel lymph nodes—the first nodes that harbor cancer cells once they exit from a primary tumor—SLNB allows doctors to determine whether the cancer has spread while avoiding extensive invasive surgery. 

When investing in a specimen radiography system, performance, image quality and workflow features are critical - but service and support can make or break your experience.

A key measure reflecting both the value of healthcare services rendered and their reimbursement potential is the Relative Value Unit (RVU). Understanding how innovative medical technologies, like KUBTEC's MOZART® 3D Specimen Radiography System, could positively impact RVUs is essential for enhancing clinical outcomes, streamlining processes, and boosting revenue.

This post compares 3D Tomosynthesis and Micro-CT for intraoperative breast specimen imaging, highlighting the advantages of Tomosynthesis, such as faster imaging, higher contrast resolution, and better visualization of soft tissues. In contrast, Micro-CT, while useful for research, has limitations like slower processing times, lower contrast resolution, and workflow disruptions, making Tomosynthesis the preferred method for breast-conserving surgery.

Dealing with breast cancer is an exceptionally challenging experience, both physically and emotionally. Undergoing surgery can be one of the most daunting parts, so imagine if you had to come back for an additional surgery. Unfortunately, this is a reality today for many breast cancer patients, with 1 in 5 who undergo breast conserving surgery requiring a repeat surgery. In the United States alone, this equates to a staggering 75,000 repeat breast surgeries every year.